Childhood-onset Multifocal Motor Neuropathy with Conduction Blocks
Neurol 66:922-924, Moroni,I.,et al, 2006
Combinations of the Presence or Absence of Cerebral Microbleeds and Advanced White Matter Hyperintensity as Predictors of Subsequent Stroke Types
AJNR 27:830-835, Naka,H.,et al, 2006
Bilateral Cerebellar Infarction Caused by Dominant Medial Posterior Inferior Cerebellar Artery
Neurol 66:1125-1126, Han,S.W.,et al, 2006
Treatment of Low Back Pain by Acupressure and Physical Therapy: Randomised Controlled Trial
BMJ 332:696-698,680, Hsieh,L.L.-C.,et al, 2006
Magnetic Resonance Imaging as a Surrogate Outcome Measure of Disability in Multiple Sclerosis: Have We Been Overly Harsh in Our Assessment?
Ann Neurol 59:597-605, Goodin,D.S., 2006
Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should be Treated at the Time of Diagnosis
Arch Neurol 63:614-619, Frohman,E.M.,et al, 2006
Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis
Arch Neurol 63:611-619, Pittock,S.J.,et al, 2006
Increase in Multiple Sclerosis Relapse Rate Following in vitro Fertilization
Neurol 66:1280-1281, Laplaud,D.-A.,et al, 2006
Prospective Study of Symptomatic Atherothrombotic Intracranial Stenoses. The GESICA Study
Neurol 66:1187-1191, Mazighi,M.,et al, 2006
Clinical Outcome After First and Recurrent Hemorrhage in Patients With Untreated Brain Arteriovenous Malformation
Stroke 37:1243-1247, Choi,J.H.,et al, 2006
Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy
Stroke 37:1217-1220, Somerfield,J.,et al, 2006
Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006
MRI T2 Lesion Burden in Multiple Sclerosis. A Plateauing Relationship with Clinical Disability.
Neurol 66:1384-1389, Li,D.K.B.,et al, 2006
Multiple Sclerosis: New Insights and Trends
AJNR 27:954-957, Inglese,M., 2006
Past Adult Lead Exposure is Linked to Neurodegeneration Measured by Brain MRI
Neurol 66:1476-1484,1464, Stewart,W.F.,et al, 2006
Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006
Efficacy and Safety of Intranasal Lorazepam Versus Intramuscular Paraldehyde for Protracted Convulsions in Children: An Open Randomised Trial
Lancet 367:1591-1597,1555, Ahmad,S.,et al, 2006
Accuracy of Magnetic Resonance Imaging for the Diagnosis of Multiple Sclerosis: Systematic Review
BMJ 332:875-878, Whiting P.,et al, 2006
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
JAMA 295:2483-2491,2535, Aoyama,H.,et al, 2006
Multiple Sclerosis: The Role of MR Imaging
AJNR 27:1165-1176, Ge,Y., 2006
A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006
Tetanus Vaccination and Risk of Multiple Sclerosis: A Systematic Review
Neurol 67:212-215, Hernn,M.A.,et al, 2006
The Clinical Features, MRI Findings, and Outcome of Optic Neuritis in Children
Neurol 67:258-262, Wilejto,M.,et al, 2006
Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006
Premenstrual Multiple Sclerosis Pseudoexacerbations: Role of Body Temperature and Prevention With Aspirin
Arch Neurol 63:1005-1008, Wingerchuk,D.M. &Rodriguez,M., 2006
Evolution of Cerebral Arteriopathies in Childhood Arterial Ischemic Stroke
Ann Neurol 59:620-626, Danchaivijitr,N.,et al, 2006
Primary Angiitis of the Central Nervous System: Emerging Variants
Q J Med 98:643-654, Maclaren,K.,et al, 2005
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Central Nervous System Involvement in Hereditary Neuropathy With Liability to Pressure Palsies
Arch Neurol 62:1911-1914, Sanahuja,J.,et al, 2005
Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the "McDonald Criteria"
Ann Neurol 58:840-846, Polman,C.H.,et al, 2005
Pregnancy, Delivery, and Birth Outcome in Women with Multiple Sclerosis
Neurol 65:1961-1963, Dahl,J.,et al, 2005
Migraine and Cerebral White Matter Lesions
The Neurologist 11:19-29, Gladstone,J.P. &Dodick,D.W., 2005
Is Optic Neuritis More Benign Than Other First Attacks in Multiple Sclerosis?
Ann Neurol 57:210-215, Tintore, M., et al, 2005
Ischaemic Stroke in Young Adults: Predictors of Outcome and Recurrence
JNNP 76:191-195, Nedeltchev, K., et al, 2005
Diffusion MRI in Multiple Sclerosis
Neurol 65:1526-1532, Rovaris,M.,et al, 2005
Spatial Clustering of Hemorrhages in Probable Cere bral Amyloid Angiopathy
Ann Neurol 58:459-462, Rosand,J.,et al, 2005
Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005
Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005
Pregnancy Outcomes During Treatment with Interferon Beta-1a in Patients with Multiple Sclerosis
Neurol 65:802-806, Sandberg-Wollheim,M.,et al, 2005
Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis
Neurol 65:812-819,788, Rog,D.J.,et al, 2005
Bilateral Involvement of a Single Cranial Nerve:Analysis of 578 Cases
Neurol 65:950-, Keane,J.R., 2005
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
Stroke 36:1115-1119, Marini,C.,et al, 2005
Overdiagnosis of Multiple Sclerosis and Magnetic Resonance Imaging Criteria
Ann Neurol 58:781-783, Nielsen,J.M.,et al, 2005
Intracerebral Haemorrhage in CADASIL
JNNP 76:1606-1607, Ragoschke-Schumm,A.,et al, 2005
Whole-Body Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy
NEJM 353:1574-1584, Shankaran,S.,et al, 2005
Changes in the Ascertainment of Multiple Sclerosis
Neurol 65:1066-1070, Marrie,R.A.,et al, 2005
Status Epilepticus: An Evidence Based Guide
BMJ 331:673-677, Walker,M., 2005
Acute Disseminated Encephalomyelitis
Arch Neurol 62:1673-1680, Menge,T.,et al, 2005
Multiple Cranial Nerve Palsies
Arch Neurol 62:1714-1717, Keane,J.R., 2005
Bilateral Third Nerve Palsy and Temporal Arteritis
Arch Neurol 62:1766-1768, Lazaridis,C.,et al, 2005